Takeda appoints Annapurna Das as the General Manager, India Operations
Annapurna will lead the company in India ensuring patient access to its highly innovative medicines and vaccines
Annapurna will lead the company in India ensuring patient access to its highly innovative medicines and vaccines
EBITDA for the quarter stood at Rs 964 crore, representing an EBITDA margin of 24%
Investing considerably in production capacity for medical device packaging at its Rohrdorf and Halle sites in Germany
Sevelamer Carbonate Tablets approval consolidates the company's position in the Sevelamer segment
Investing in Malaysia's largest clinic operator to expand the healthcare business
Wipro's MPPP360 platform will assist Independent Health in streamlining the payment process to seamlessly integrate these new provisions
Acquisition encompasses a portfolio of RLT programs across a range of solid tumor indications
Keimed is a leading wholesale pharma distribution with industry leading operating metrics
Cellares will dedicate multiple Cell Shuttle and Cell Q systems with fully automated, high-throughput quality control for Bristol Myers Squibb’s exclusive use
The newly issued patent, US Patent No. 11,957,647, provides both expanded scope of protection as well as longer patent term
Subscribe To Our Newsletter & Stay Updated